A year later, none of the $1.5B for rare disease has flowed to patients

David Renwick, Interim President, Innovative Medicines Canada
This article originally appeared in The Hill Times on February 28, 2024.

It’s no secret that Canadians wait too long to access health care. No where is this more evident than for Canadians living with a rare disease. Read the full article on The Hill Times.